XML 55 R36.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of profit (loss) before the provision for income taxes
   
Year Ended December 31,
 
   
2022
   
2023
   
2024
 
       
   
(in thousands)
 
Israel          
  $
(170,138
)
  $
(120,835
)
  $
(74,754
)

Foreign

   
(31,279
)
   
(10,961
)
   
(4,639
)

 

                       
Total          
  $
(201,417
)
  $
(131,797
)
  $
(79,393
)
Schedule of provision for income taxes
   
Year Ended December 31,
 
   
2022
   
2023
   
2024
 
   
(in thousands)
 
Current:
                 
Israel          
 
$
-
   
$
-
   
$
23
 
Foreign          
 
 
1,512
   
 
2,059
     
2,638
 
                         
Total current income tax expense          
 
$
1,512
   
$
2,059
   
$
2,661
 
                         
Deferred:
                       
Israel          
  $
-
    $
-
    $
-
 
Foreign
   
(7,524
)
   
(51
)
   
(6,506
)
                         
Total deferred income tax benefit          
   
(7,524
)
   
(51
)
   
(6,506
)
                         
Total provision for income taxes          
 
$
(6,012
)
 
$
2,008
   
$
(3,845
)
Schedule of effective income tax rate reconciliation
   
Year Ended December 31,
 
   
2022
   
2023
   
2024
 
   
(in thousands)
 
Theoretical income tax expense (benefit)          
 
$
(46,326
)
 
$
(30,313
)
 
$
(18,260
)
Change in valuation allowance          
   
43,134
     
28,471
     
15,043
 
Return to provision true ups
   
395
     
884
     
143
 
Foreign tax rate differentials          
   
311
     
352
     
753
 
Shared Based Compensations non-deductible (taxable)
   
(929
)
   
2,402
     
(1,159
)
Non-deductible expenses          
   
820
     
512
     
298
 
Tax rate change impact
   
(1,883
)
   
(139
)
   
124
 
Foreign exchange impact          
   
874
     
(430
)
   
(511
)
State Taxes
   
(316
)
   
170
     
(299
)
Valuation allowance on acquisition balances
   
(3,482
)
   
-
     
-
 
R&D credits
   
-
     
(208
)
   
(1,427
)
Other          
   
1,390
     
307
     
1,450
 
                         
Total          
 
$
(6,012
)
 
$
2,008
    $
(3,845
)
Schedule of deferred tax assets and liabilities
   
December 31,
 
   
2023
   
2024
 
   
(in thousands)
 
Deferred tax assets:
           
Net operating loss carryforwards *)          
  $
88,395
    $
93,943
 
Research and development expenses          
   
21,056
     
26,545
 
Leasing liabilities          
   
5,350
     
5,615
 
Accruals and reserves          
   
460
     
683
 
Share-based compensation
   
8,902
     
12,505
 
R&D tax credits
   
351
     
2,843
 
Bad debt
   
149
     
244
 
Capital losses
   
-
     
129
 
Gross deferred tax assets          
   
124,663
     
142,507
 
Valuation allowance          
   
(107,682
)
   
(122,725
)
     Total deferred tax assets          
   
16,981
     
19,782
 
                 
Deferred tax liabilities:
               
Deferred contract acquisition costs          
   
570
     
818
 
Leasing assets          
   
4,944
     
4,946
 
Property and equipment          
   
171
     
194
 
Intangibles
   
17,790
     
13,824
 
Other
   
13
     
-
 
Gross deferred tax liabilities          
   
23,488
     
19,782
 
                 
Deferred taxes assets (liabilities), net          
  $
(6,507
)
  $
-
 
 
*) Refer to note 11g.
Schedule of unrecognized tax benefits
   
December 31,
 
   
2023
   
2024
 
   
(in thousands)
 
             
Beginning balance          
  $
53,670
    $
-
 
Increases related to tax positions taken during the current year          
   
-
     
-
 
Decrease related to tax positions taken during the current year          
   
(53,670
)
   
-
 
Ending balance          
  $
-
    $
-